BTW
AGN

Boston Trust Walden’s Allergan plc AGN Stock Holding History

Boston Trust Walden’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-686
Closed -$208K – 357
2015
Q2 		$208K Sell
686
-2,326
-77% -$694K ﹤0.01% 344
2015
Q1 		$896K Buy
+3,012
New +$859K 0.01% 289

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Boston Trust Walden's AGN Position: Q3 2015 in Review

Boston Trust Walden sold out of Allergan plc (AGN) in Q3 2015, closing a stake of 686 shares — an estimated $208K sold.

Boston Trust Walden first reported a position in AGN in Q1 2015 and held it in 2 quarters. The position peaked at $896K in Q1 2015. 1,056 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

  • Boston Trust Walden reported no remaining Allergan plc position as of Q3 2015 after selling out during the quarter.
  • Boston Trust Walden sold 686 Allergan plc shares in Q3 2015, an estimated $208K.
  • Boston Trust Walden first reported a position in Allergan plc in Q1 2015 and held it in 2 quarters.
  • Boston Trust Walden's Allergan plc position peaked at $896K in Q1 2015.
  • 1,056 funds tracked by Wall St. Rank held Allergan plc as of Q3 2015.

Based on Boston Trust Walden's 13F filing for Q3 2015, filed 29 Oct 2015.